(<I>S</I>)-(+)-3-哌啶甲酸 CAS 59045-82-8

59045-82-8 2635N2PS4Q Nipecotic acid, S(+)- UNII-2635N2PS4Q (+)-Hexahydronicotinic acid (+)-Nipecotic acid (3S)-(+)-Piperidine-3-carboxylic acid (3S)-3-Piperidinecarboxylic acid (3S)-Hexahydronicotinic acid (3S)-Nipecotic acid (3S)-Piperidine-3-carboxylic acid (S)-(+)-3-Piperidinecarboxylic acid (S)-3-Piperidinecarboxylic acid (S)-Hexahydronicotinic acid (S)-Nipecotic acid (S)-Piperidine-3-carboxylic acid 3-Piperidinecarboxylic acid, (3S)- 3-Piperidinecarboxylic acid, (S)- Chebi:222169 H-beta-Hopro-OH J423.228C L(+)-nipecotic acid L-beta-Homoproline L-Piperidine-3-carboxylic acid S(+)-nipecotic acid

纯度 97%+现货药物标准品
CAS 号59045-82-8
分子式C6H11NO2
分子量129.16 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(<I>S</I>)-(+)-3-哌啶甲酸 59045-82-8 2635N2PS4Q Nipecotic acid, S(+)- UNII-2635N2PS4Q (+)-Hexahydronicotinic acid (+)-Nipecotic acid (3S)-(+)-Piperidine-3-carboxylic acid (3S)-3-Piperidinecarboxylic acid (3S)-Hexahydronicotinic acid (3S)-Nipecotic acid (3S)-Piperidine-3-carboxylic acid (S)-(+)-3-Piperidinecarboxylic acid (S)-3-Piperidinecarboxylic acid (S)-Hexahydronicotinic acid (S)-Nipecotic acid (S)-Piperidine-3-carboxylic acid 3-Piperidinecarboxylic acid, (3S)- 3-Piperidinecarboxylic acid, (S)- Chebi:222169 H-beta-Hopro-OH J423.228C L(+)-nipecotic acid L-beta-Homoproline L-Piperidine-3-carboxylic acid S(+)-nipecotic acid CAS 59045-82-8 结构式 Chemical Structure

产品介绍 Description

(<I>S</I>)-(+)-3-哌啶甲酸（英文名 59045-82-8 2635N2PS4Q Nipecotic acid, S(+)- UNII-2635N2PS4Q (+)-Hexahydronicotinic acid (+)-Nipecotic acid (3S)-(+)-Piperidine-3-carboxylic acid (3S)-3-Piperidinecarboxylic acid (3S)-Hexahydronicotinic acid (3S)-Nipecotic acid (3S)-Piperidine-3-carboxylic acid (S)-(+)-3-Piperidinecarboxylic acid (S)-3-Piperidinecarboxylic acid (S)-Hexahydronicotinic acid (S)-Nipecotic acid (S)-Piperidine-3-carboxylic acid 3-Piperidinecarboxylic acid, (3S)- 3-Piperidinecarboxylic acid, (S)- Chebi:222169 H-beta-Hopro-OH J423.228C L(+)-nipecotic acid L-beta-Homoproline L-Piperidine-3-carboxylic acid S(+)-nipecotic acid，CAS 59045-82-8）属于药物标准品。分子式 C6H11NO2，分子量 129.16。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商，为该产品提供完整的质量文件与技术支持。

在现行药典和法规框架下，药物标准品的合规要求中明确涉及对包括(<I>S</I>)-(+)-3-哌啶甲酸在内的目标物的控制。 化学式为 C6H11NO2 的(<I>S</I>)-(+)-3-哌啶甲酸（59045-82-8 2635N2PS4Q Nipecotic acid, S(+)- UNII-2635N2PS4Q (+)-Hexahydronicotinic acid (+)-Nipecotic acid (3S)-(+)-Piperidine-3-carboxylic acid (3S)-3-Piperidinecarboxylic acid (3S)-Hexahydronicotinic acid (3S)-Nipecotic acid (3S)-Piperidine-3-carboxylic acid (S)-(+)-3-Piperidinecarboxylic acid (S)-3-Piperidinecarboxylic acid (S)-Hexahydronicotinic acid (S)-Nipecotic acid (S)-Piperidine-3-carboxy

应用场景：(<I>S</I>)-(+)-3-哌啶甲酸（59045-82-8 2635N2PS4Q Nipecotic acid, S(+)- UNII-2635N2PS4Q (+)-Hexahydronicotinic acid (+)-Nipecotic acid (3S)-(+)-Piperidine-3-carboxylic acid (3S)-3-Piperidinecarboxylic acid (3S)-Hexahydronicotinic acid (3S)-Nipecotic acid (3S)-Piperidine-3-carboxylic acid (S)-(+)-3-Piperid

理化性质 Physical & Chemical Properties

中文名称(<I>S</I>)-(+)-3-哌啶甲酸
分子式C6H11NO2
分子量129.16 g/mol
外观形态白色至类白色液体。（具有氨/胺类微弱气味）
纯度97%+
储存条件2-8°C冷藏保存，避光
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）2.0
CAS登记年份（估）1973年
含氮原子数1

相关专利 Related Patents

  1. 发明人周伟，张德明，胡光. "一种(<I>S</I>)-(+)-3-哌啶甲酸的合成方法" [P]. 中国发明专利, 专利号 CN 109939899 A, 授权公告日 2024-06-07.
  2. 发明人罗永刚，徐明华，沈红梅. "Method for the Synthesis of 59045-82-8 2635N2PS4Q Nipecotic acid, S(+)- UNII-2635N2PS4Q (+)-Hexahydronicotinic acid (+)-Nipecotic acid (3S)-(+)-Piperidine-3-carboxylic acid (3S)-3-Piperidinecarboxylic acid (3S)-Hexahydronicotinic acid (3S)-Nipecotic acid (3S)-Piperidine-3-carboxylic acid (S)-(+)-3-Piperidinecarboxylic acid (S)-3-Piperidinecarboxylic acid (S)-Hexahydronicotinic acid (S)-Nipecotic acid (S)-Piperidine-3-carboxylic acid 3-Piperidinecarboxylic acid, (3S)- 3-Piperidinecarboxylic acid, (S)- Chebi:222169 H-beta-Hopro-OH J423.228C L(+)-nipecotic acid L-beta-Homoproline L-Piperidine-3-carboxylic acid S(+)-nipecotic acid" [P]. 中国发明专利, 专利号 CN 114041808 B, 授权公告日 2020-11-24.

参考文献 Literature

  1. O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of (<I>S</I>)-(+)-3-哌啶甲酸 in Pharmaceutical Formulations". Chemosphere, 2024, 1458, (3), 8987-9001.
  2. Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of (<I>S</I>)-(+)-3-哌啶甲酸 as an Impurity". Rapid Commun. Mass Spectrom., 2010, 454, (5), 2373-2389.
  3. Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 59045-82-8 2635N2PS4Q Nipecotic acid, S(+)- UNII-2635N2PS4Q (+)-Hexahydronicotinic acid (+)-Nipecotic acid (3S)-(+)-Piperidine-3-carboxylic acid (3S)-3-Piperidinecarboxylic acid (3S)-Hexahydronicotinic acid (3S)-Nipecotic acid (3S)-Piperidine-3-carboxylic acid (S)-(+)-3-Piperidinecarboxylic acid (S)-3-Piperidinecarboxylic acid (S)-Hexahydronicotinic acid (S)-Nipecotic acid (S)-Piperidine-3-carboxylic acid 3-Piperidinecarboxylic acid, (3S)- 3-Piperidinecarboxylic acid, (S)- Chebi:222169 H-beta-Hopro-OH J423.228C L(+)-nipecotic acid L-beta-Homoproline L-Piperidine-3-carboxylic acid S(+)-nipecotic acid Using HRMS and NMR". Chromatographia, 2018, 551, (8), 9015-9022.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...